Cancer Immunotherapy Market see growth of 14.0% CAGR reaching at USD 119.39 billion by 2021

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, rising healthcare expenditure, and increased access to medical insurance in developed countries are driving growth in the caner immunotherapy market. However, stringent regulatory policies and side-effects associated with cancer therapy are the major factors restraining the growth of this market.

 

Request a Free Sample copy of This Premium Research Report:  https://watchersofmarkets.com/products/cancer-immunotherapy-market-by-type-monoclonal-antibodies-cancer-vaccines-check-point-inhibitors-immunomodulators-application-lung-breast-colorectal-melanoma-prostate-head-neck-end-user-hospital-and-clinics-global-forecast-to-2021#tab-questions

                                                         

The global cancer immunotherapy market has been segmented on the basis of type, application, end user, and region. The monoclonal antibodies segment is expected to register the highest growth rate in the cancer immunotherapy market, by type, during the forecast period. Factors such as high success rate and less recovery time are contributing to the high growth in this segment.

 

Based on application, the global cancer immunotherapy market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head & neck cancer, and others (renal cell carcinoma, cervical, gastric, and lymphoma). The lung cancer segment is expected to witness the highest CAGR from 2016 to 2021, primarily due to the rising prevalence of this type of cancer.

 

Based on end users, the global cancer immunotherapy market is segmented into hospitals and clinics & others. The hospitals segment is expected to account for the largest share of the global cancer immunotherapy market in 2016. The rise in healthcare spending has resulted in the increasing use of drugs in hospitals.

 

Geographically, the cancer immunotherapy market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of North America can be attributed to the growing aging population and the increased funding from government and non-government agencies in order to increase the research capacity.

 

Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by the market players to maintain and increase their shares in the market. The above-mentioned market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output, in order to remain successful in the cancer immunotherapy market.

 

Read more on this report:  https://watchersofmarkets.com/products/cancer-immunotherapy-market-by-type-monoclonal-antibodies-cancer-vaccines-check-point-inhibitors-immunomodulators-application-lung-breast-colorectal-melanoma-prostate-head-neck-end-user-hospital-and-clinics-global-forecast-to-2021

 

Breakdown of primary participant profiles:

  • By Company Type: Tier 1—25%, Tier 2—30%, and Tier 3—45%
  • By Designation: C-Level Executives—45%, Directors—35%, and Others—20%
  • By Region: North America—40%, Europe—30%, APAC—25%, and RoW—5%

 

The key players operating in this market are Intel (US), NVIDIA (US), Xilinx (US), Samsung Electronics (South Korea), Facebook (US), Micron Technology (US), IBM (US), Google (US), Microsoft (US), and AWS (US).

 

Related Report:

Immunotherapy Drugs Market by Type of Drugs (Adult Vaccines Checkpoint Inhibitors Interferons Alpha) Therapy Area (Cancer Autoimmune Diseases Infectious Diseases) End-User (Hospitals) Region (North America Asia-Pacific) - Global Forecast to 2021 rt

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.

In this report, the immunotherapy drugs market is segmented on the basis of type of drugs, therapy area, end user, and region. Increasing adoption of targeted therapies with fewer side effects, quicker drug approval processes, and high prevalence rate of lifestyle diseases are major growth drivers of this market. On the other hand, the high cost of immunotherapy treatment, and high attrition rate in the product development cycle are the major factors hindering the growth of the immunotherapy drugs market. However, rising opportunities in the emerging markets, and immunotherapy as an alternative to chemotherapy for first line treatment are the factors supporting the growth of immunotherapy drugs market.

Read More: v https://watchersofmarkets.com/products/immunotherapy-drugs-market-by-type-of-drugs-adult-vaccines-checkpoint-inhibitors-interferons-alpha-therapy-area-cancer-autoimmune-diseases-infectious-diseases-end-user-hospitals-region-north-america-asia-pacific-global-forecast-to-2021

About Us:

We are a leading market research store (headquartered in The Hague, Netherlands) bringing to you market research insights, analysis and data from many market research publishers around the globe.

Our experienced market research consultants understand a client’s research requirements in precise manner and get as many proposals around the globe as possible on the table suiting your budget and mapping your research goals.

Our only motivation is to provide clients with precise insights into their respective niche markets and offering them the most comprehensive portfolio of business information products.

 

Contact:

Watchers of Markets

Henriëtte van der Meydreef 144,2492 JG, Den Haag, Netherlands.

Website: https://watchersofmarkets.com/

Phone number: +31- 85 888 111 6

Email Id : [email protected]

 

Posted by on Saturday September 15 2018, 9:18 AM EST. All trademarks acknowledged. Filed under Biotechnology, Business & Financial Services, Business Services, Diagnostics, Featured Press Release, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals, Technology Hardware & Equipment, Technology, Media, & Telecommunications. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in